{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:48:59Z","timestamp":1793299739593,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejso.2021.05.014","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:28:00Z","timestamp":1620944880000},"page":"2363-2368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study"],"prefix":"10.1016","volume":"47","author":[{"given":"Feiling","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijian","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2021.05.014_bib1","series-title":"Hepatobiliary Cancers. Version 5. 2020","year":"2020"},{"key":"10.1016\/j.ejso.2021.05.014_bib2","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"Razumilava","year":"2014","journal-title":"Cholangiocarcinoma, Lancet"},{"key":"10.1016\/j.ejso.2021.05.014_bib3","first-page":"967472","article-title":"Gallbladder cancer in the 21st century","volume":"2015","author":"Kanthan","year":"2015","journal-title":"J\u00a0Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib4","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2021.05.014_bib5","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archsurg.2012.1962","article-title":"Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients","volume":"147","author":"Ribero","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2021.05.014_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00270-010-9849-3","article-title":"Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience","volume":"33","author":"Carrafiello","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejso.2021.05.014_bib8","doi-asserted-by":"crossref","first-page":"W205","DOI":"10.2214\/AJR.10.4937","article-title":"Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma","volume":"196","author":"Kim","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2021.05.014_bib9","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cncr.25625","article-title":"Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study","volume":"117","author":"Kiefer","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.05.014_bib10","first-page":"437","article-title":"Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy","volume":"24","author":"Kuhlmann","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2021.05.014_bib11","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1245\/s10434-013-3127-y","article-title":"Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis","volume":"20","author":"Hyder","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib12","first-page":"155","article-title":"Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis","volume":"4","author":"Eckmann","year":"2011","journal-title":"Gastrointest Cancer Res"},{"issue":"Suppl 6","key":"10.1016\/j.ejso.2021.05.014_bib13","first-page":"VI1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document","volume":"51","author":"Khan","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.ejso.2021.05.014_bib14","first-page":"83","article-title":"Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer","volume":"16","author":"Sugarbaker","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib15","first-page":"164","article-title":"Intra-Peritoneal Chemo-Hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report","volume":"76","author":"Gilly","year":"1991","journal-title":"Int Surg"},{"key":"10.1016\/j.ejso.2021.05.014_bib16","doi-asserted-by":"crossref","first-page":"6906","DOI":"10.3748\/wjg.v22.i30.6906","article-title":"Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies","volume":"22","author":"Li","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2021.05.014_bib17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12957-018-1482-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report","volume":"16","author":"Thorgersen","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jso.23062","article-title":"Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results","volume":"106","author":"Golse","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib19","article-title":"Treatment of hypermyoglobinemia after CRS\u00a0+ HIPEC for patients with peritoneal carcinomatosis: a retrospective comparative study","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ejso.2021.05.014_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12957-020-01898-5","article-title":"Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?","volume":"18","author":"Leigh","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014628","article-title":"Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC: a case report and literature review","volume":"98","author":"Ji","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ejso.2021.05.014_bib22","article-title":"Peritoneal metastasis of cholangiocarcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at the instituto nacional de Cancerolog\u00eda, Colombia","volume":"12","author":"Hernandez","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ejso.2021.05.014_bib23","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ejso.2018.04.023","article-title":"Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: a multi-institutional cohort from PSOGI and BIG RENAPE groups","volume":"44","author":"Amblard","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amsu.2017.08.009","article-title":"Peritoneal metastases of rare carcinomas treated with cytoreductive surgery and HIPEC - a single center case series","volume":"22","author":"Brandl","year":"2017","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.ejso.2021.05.014_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022647","article-title":"CRS\u200a+\u200aHIPEC combined with IP\u200a+\u200aIV chemotherapy for gastric signet-ring cell carcinoma: case report of long-term survival","volume":"99","author":"Yan","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ejso.2021.05.014_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02656736.2017.1283065","article-title":"Current status and future prospects of clinical trials on CRS\u2009+\u2009HIPEC for gastric cancer peritoneal metastases","volume":"33","author":"Ji","year":"2017","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2021.05.014_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis","volume":"41","author":"Huo","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib28","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J","article-title":"Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis","volume":"88","author":"Beaujard","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2021.05.014_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1470-2045(04)01425-1","article-title":"Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia","volume":"5","author":"Glehen","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2003.06.139","article-title":"Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study","volume":"21","author":"Glehen","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7819-10-29","article-title":"High-pressure intrapleural chemotherapy: feasibility in the pig model","volume":"10","author":"Facy","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/SLA.0b013e3182193143","article-title":"Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model","volume":"254","author":"Piche","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2021.05.014_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejca.2013.09.024","article-title":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","volume":"50","author":"Elias","year":"2014","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2021.05.014_bib34","series-title":"Cancer du c\u00f4lon non m\u00e9tastatique","author":"Lecomte","year":"2019"},{"key":"10.1016\/j.ejso.2021.05.014_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib36","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3802\/jgo.2018.29.e47","article-title":"Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study","volume":"29","author":"Elzarkaa","year":"2018","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib37","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ejso.2018.07.003","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib38","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.3892\/ol.2016.4414","article-title":"Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejso.2021.05.014_bib39","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3892\/or.2017.5570","article-title":"Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection","volume":"37","author":"Ba","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejso.2021.05.014_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12894-019-0543-8","article-title":"Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study","volume":"19","author":"Ba","year":"2019","journal-title":"BMC Urol"},{"key":"10.1016\/j.ejso.2021.05.014_bib41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib42","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.2005.51.008","article-title":"Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial","volume":"23","author":"Knox","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1016209901417","article-title":"Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas","volume":"20","author":"Kuhn","year":"2002","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.ejso.2021.05.014_bib44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.coc.0000203742.22828.bb","article-title":"Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma","volume":"29","author":"Lee","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2021.05.014_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000493493","article-title":"Hyperthermic intraperitoneal chemotherapy - fading perspective in the light of modern systemic chemotherapy?","volume":"34","author":"Garg","year":"2018","journal-title":"Vis Med"},{"key":"10.1016\/j.ejso.2021.05.014_bib46","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832100490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832100490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:39:38Z","timestamp":1760060378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832100490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S074879832100490X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.014","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2021.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}